Koers RavenQuest BioMed Inc. Canadian Securities Exchange
Aandelen
RQB
CA7543871080
Bedrijfsondersteunende diensten
Omzet 2017 | 0,11 0,15 0,1 | Omzet 2018 | 1,26 1,71 1,16 | Marktkapitalisatie | 58,71 mln. 79,94 mln. 54,07 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -3 mln. -4,08 mln. -2,76 mln. | Nettowinst (verlies) 2018 | -30 mln. -40,85 mln. -27,63 mln. | EV/omzet 2017 * | - |
Nettoliquiditeiten 2017 | 3,15 mln. 4,28 mln. 2,9 mln. | Nettoschuld 2018 | 12,9 mln. 17,56 mln. 11,88 mln. | EV/omzet 2018 | 56.975.119 x |
K/w-verhouding 2017 * |
-
| K/w-verhouding 2018 |
-1,55
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 89,48% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 35 | 27-11-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 35 | 27-11-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,83% | 7,78 mld. | |
-31,02% | 3,27 mld. | |
+10,30% | 2,75 mld. | |
-9,99% | 1,08 mld. | |
+19,89% | 829 mln. | |
-9,40% | 702 mln. | |
-4,90% | 598 mln. | |
-13,48% | 576 mln. | |
-11,51% | 519 mln. |